Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
European Heart Journal|April 15, 2014
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trialDaniel Lindholm, Christoph Varenhorst, Christopher P Cannon, et al.European Heart Journal|August 2, 2011
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomesRobert F Storey, Richard C Becker, Robert A Harrington, et al.Clinical Chemistry|December 1, 2011
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes studyÅxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.American Heart Journal|September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trialJan H Cornel, Richard C Becker, Shaun G Goodman, et al.Journal of the American College of Cardiology|May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudyBenjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.Circulation. Cardiovascular Quality and Outcomes|September 20, 2012
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan James, Richard C Becker, et al.The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.BMJ (Clinical Research Ed.)|June 17, 2016
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trialJeroen Jaspers Focks, Marc A Brouwer, Daniel M Wojdyla, et al.Lancet (London, England)|September 3, 2016
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre studyLars Wallentin, Lars Lindhagen, Elisabet Ärnström, et al.Circulation. Arrhythmia and Electrophysiology|January 27, 2016
Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) TrialAn H Bui, Christopher P Cannon, Philippe Gabriel Steg, et al.Pageof 10